Mayne Pharma Group Ltd has released a press release.
2015 Appendix 4E & Annual Report
Filed with ASX ·
Watch Mayne Pharma's latest callMayne Pharma Group (ASX:MYX) Q4 2026 Earnings Call · Replay · Aug 26Read the transcript of Mayne Pharma Group (ASX:MYX) Q4 2026 Earnings Call6ix hasn’t read this filing yet.
Mayne Pharma Group Ltd. on 6ix
Story so far
Earlier from Mayne Pharma
- US Sales of Doryx Update
- US Oxycodone franchise restructure and Doryx re-launch
- US Court decides on Doryx 161 Patent
- Successful Phase II SUBACAP trial
- Successful EU SUBA Clinical Study
Later from Mayne Pharma
- Mayne Pharma receives FDA approval for Doryx MPC tablets
- MYX receives first generic approval of Tikosyn capsules
- MYX announces acquisition of US generic product portfolio
- Completion institutional entitlement offer and placement
- MYX announces settlement from patent infringement case
Follow Mayne Pharma into a list and get an email when it puts out news.
Follow Mayne Pharma